MariMed Inc. (MRMD)
|Net Income (ttm)||-80.42M|
|Trading Day||January 15|
|Day's Range||0.7900 - 0.9000|
|52-Week Range||0.1 - 0.84|
While cannabis legalization may not be a slam-dunk, that hasn't stopped investors from sending marijuana penny stocks to higher highs. The post 4 Marijuana Penny Stocks Winning Under Democrati...
MariMed prints positive net earnings and is set to continue this trend; With #1 selling edibles products, MariMed could grow revenues beyond projections as more dispensaries take on new products.
NORWOOD, Mass., Jan. 4, 2021 /PRNewswire/ -- MariMed Inc. (MRMD:OTCQX) (the "Company" or "MariMed"), a leading multi-state cannabis operator based in Massachusetts, is pleased to announce that...
Financial leverage measures the degree to which a company uses debt to fund its operations. Leverage can magnify gains as well as losses.
MariMed Introduces World-Famous ‘Tikun Olam' Genetics, Flower and Products into Massachusetts Market
NORWOOD, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- International cannabis pioneer Tikun Olam's award-winning heirloom cannabis products will be available for purchase in Massachusetts this week...
MariMed provides consulting services for the design, development, operation, management, and optimization of medical cannabis cultivation, production, and dispensary facilities. It also develops and manages facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis, and cannabis-infused products under the Kalm Fusion, Betty's Eddies, and Nature's Heritage brand name. In addition, the company offers regulatory, accounting, human resources, and administrative services. It has secured 13 cannabis licenses for... [Read more...]
Drug Manufacturers-Specialty & Generic
Robert N. Fireman
|Stock Exchange |
|Ticker Symbol |
In 2019, MariMed's revenue was $45.60 million, an increase of 284.79% compared to the previous year's $11.85 million. Losses were -$81.18 million, 496.8% more than in 2018.